Vegetative pyoderma gangrenosum: This type, also known as superficial pyoderma gangrenosum, causes ulcers that are not particularly deep or painful. It usually develops in people with no ...

This research is significant as Humira is the only approved treatment for Pyoderma Gangrenosum in Japan. The study tested Humira (Adalimumab), an injectable medication, on approximately 60 ...

US Food and Drug Administration awards Fast Track designation for the treatment of ulcerative pyoderma gangrenosumFast track follows recently reported orphan drug designation by both US FDA and ...

“A MID of 7-day pain scores for pyoderma gangrenosum was a 2-point improvement on an NRS,” the authors wrote. “Improvement of 2 or more points in pain may be an indication that a patient is ...

METHODOLOGY: To help determine whether a patient with pyoderma gangrenosum is responding to treatment, researchers used a patient global assessment (PGA) score to establish a minimal important ...

Orphan Drug Designation granted for treatment of pyoderma gangrenosum (PG) from US FDA and EMAProductive end-of-phase II meeting with FDA held for PG; dialogue ongoing related to Phase III program ...